Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7,000 | 4 | 78.4% |
| Consulting Fee | $1,875 | 1 | 21.0% |
| Food and Beverage | $49.58 | 2 | 0.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BioNTech SE | $7,000 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,875 | 1 | $0 (2020) |
| PFIZER INC. | $49.58 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,000 | 4 | BioNTech SE ($7,000) |
| 2022 | $23.58 | 1 | PFIZER INC. ($23.58) |
| 2020 | $1,875 | 1 | Merck Sharp & Dohme Corporation ($1,875) |
| 2018 | $26.00 | 1 | PFIZER INC. ($26.00) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | BioNTech SE | — | — | Cash or cash equivalent | $2,450.00 | Research |
| Study: BNT165-02 | ||||||
| 06/20/2024 | BioNTech SE | — | — | Cash or cash equivalent | $1,575.00 | Research |
| Study: BNT165-02 | ||||||
| 04/04/2024 | BioNTech SE | — | — | Cash or cash equivalent | $1,750.00 | Research |
| Study: BNT165-02 | ||||||
| 03/21/2024 | BioNTech SE | — | — | Cash or cash equivalent | $1,225.00 | Research |
| Study: BNT165-02 | ||||||
| 06/20/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: VACCINES | ||||||
| 08/19/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| 04/18/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: VACCINES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BNT165-02 | BioNTech SE | $7,000 | 4 |
About Dr. Stephen Obaro, M.D
Dr. Stephen Obaro, M.D is a Pediatric Infectious Diseases healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1982800132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Obaro, M.D has received a total of $8,925 in payments from pharmaceutical and medical device companies, with $7,000 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "" ($7,000).
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Birmingham, AL
- Active Since 06/25/2007
- Last Updated 06/22/2023
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1982800132
Products in Payments
- PREVNAR - 13 (Biological) $26.00
- PREVNAR 20 (Biological) $23.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Infectious Diseases Doctors in Birmingham
Richard Whitley, M.d, M.D
Pediatric Infectious Diseases — Payments: $1.8M
David Kimberlin, M.d, M.D
Pediatric Infectious Diseases — Payments: $87,981
William Britt, M.d, M.D
Pediatric Infectious Diseases — Payments: $16,763
Shannon Ross, M.d, M.D
Pediatric Infectious Diseases — Payments: $10,954
Craig Wilson, M.d, M.D
Pediatric Infectious Diseases — Payments: $89.09
Sergio Stagno, M.d, M.D
Pediatric Infectious Diseases